Hide metadata

dc.date.accessioned2022-12-20T16:38:59Z
dc.date.available2022-12-20T16:38:59Z
dc.date.created2022-11-17T13:26:59Z
dc.date.issued2022
dc.identifier.citationHenriksen, Ben Tore Krogseth, Maria Thy Nguyen, Caroline Mathiesen, Liv Davies, Maren Nordsveen Andersen, Randi Dovland Andersson, Yvonne . Medication management for patients with hip fracture at a regional hospital and associated primary care units in Norway: a descriptive study based on a survey of clinicians' experience and a review of patient records. BMJ Open. 2022, 12
dc.identifier.urihttp://hdl.handle.net/10852/98254
dc.description.abstractObjective: Patients with hip fracture are at high risk of medication errors due to a combination of high age, comorbidities, polypharmacy and several care transitions after fracture. The aim was to study medication management tasks concerning patient safety: medication reconciliation, medication review and communication of key medication information in care transitions. Design: Descriptive study comprising a self-administered clinician survey (MedHipPro-Q) and a retrospective review of hospital medical records of patients with hip fracture. Setting: Regional hospital and the associated primary care units (South-Eastern Norway). Participants: The survey received responses from 253 clinicians, 61 medical doctors and 192 nurses, involved in the medication management of patients with hip fracture, from acute admittance to the regional hospital, through an in-hospital fast track, primary care rehabilitation and back to permanent residence. Respondents' representativeness was unknown, introducing a risk of selection and non-response bias, and extrapolating findings should be done with caution. The patient records review included a random sample of records of patients with hip fracture (n=50). Outcome measures: Medication reconciliation, medication review and communication of medication information from two perspectives: the clinicians' (ie, experiences with medication management) and the practice (ie, documentation of completed medication management). Results: In the survey, most clinicians stated they performed medication reconciliation (79%) and experienced that patients often arrived without a medication list after care transition (37%). Doctors agreed that more patients would benefit from medication reviews (86%). In the hospital patient records, completed medication reconciliation was documented in most patients (76%). Medication review was documented in 2 of 50 patients (4%). Discharge summary guidelines were followed fully for 3 of 50 patients (6%). Conclusion: Our study revealed a need for improved medication management for patients with hip fracture. Patients were at risk of medication information not being transferred correctly between care settings, and medication reviews seemed to be underused in clinical practice.
dc.description.abstractMedication management for patients with hip fracture at a regional hospital and associated primary care units in Norway: a descriptive study based on a survey of clinicians' experience and a review of patient records
dc.languageEN
dc.publisherBMJ Publishing Group
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleMedication management for patients with hip fracture at a regional hospital and associated primary care units in Norway: a descriptive study based on a survey of clinicians' experience and a review of patient records
dc.title.alternativeENEngelskEnglishMedication management for patients with hip fracture at a regional hospital and associated primary care units in Norway: a descriptive study based on a survey of clinicians' experience and a review of patient records
dc.typeJournal article
dc.creator.authorHenriksen, Ben Tore
dc.creator.authorKrogseth, Maria
dc.creator.authorThy Nguyen, Caroline
dc.creator.authorMathiesen, Liv
dc.creator.authorDavies, Maren Nordsveen
dc.creator.authorAndersen, Randi Dovland
dc.creator.authorAndersson, Yvonne
cristin.unitcode185,53,18,15
cristin.unitnameAvdeling for farmakologi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2075625
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMJ Open&rft.volume=12&rft.spage=&rft.date=2022
dc.identifier.jtitleBMJ Open
dc.identifier.volume12
dc.identifier.issue11
dc.identifier.pagecount10
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2022-064868
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2044-6055
dc.type.versionPublishedVersion
cristin.articleide064868


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International